Interestingly, an increasing number of reports have demonstrated that Cav‐1 regulates tumor–host interactions by promoting tumor progression, growth, metastasis, therapy resistance and cell survival in different cancer types such as breast cancer [48], lung cancer [49], bladder cancer [50], and prostate cancer [51]. This evidence concerns the gene CAV1 and urinary bladder carcinoma.